NCT07332260

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

Alzheimer's Disease and Faecal Microbiota Transplantation

• Status: Not Yet Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: University Hospital of North Norway · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.

Detailed description

Alzheimer's disease (AD) is the most common cause of dementia. Studies suggest that the gut flora may play a role in the development and/or progression of AD. The gut flora is found to be different in AD compared to healthy individuals. There is also support for a link between the gut flora and diseases affecting the brain, including AD. Stool transplantation is an established medical treatment for Clostridioides difficile infections by restoring the balance of the gut flora. In this study, gut flora (a stool solution) is transferred from a healthy individual to an individual with AD. The stool transplantation is given during a colonoscopy examination of the large bowel.

Conditions

• Alzheimer s Disease
• Faecal Microbiota Transplantation (FMT)

Interventions

Type	Name	Description
BIOLOGICAL	Biological: Preprocessed thawed donor FMT	Biological: Preprocessed FMT solution is administered to the right side of the colon during a colonoscopy.

Timeline

• Start date: 2026-01-01
• Primary completion: 2026-06-01
• Completion: 2027-01-01
• First posted: 2026-01-12
• Last updated: 2026-01-14